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A 67-year old man with a history of papillary thyroid cancer (PTC) presented with metastatic disease to the left
colon in the form of a 6.1x1.0 cm bleeding, ulcerated mass. Radiopaque surgical clips were used as fiducial markers
to localize the gross tumor volume (GTV) as well as the corresponding clinical target volume (CTV) and planning
target volume (PTV). Daily cone beam computed tomography (CBCT) image guidance was utilized to verify the
tumor position. Inter- and intrafraction movement of the tumor mass was assessed. Gastrointestinal bleeding was
controlled using palliative image-guided radiation therapy (IGRT).
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Papillary thyroid cancer (PTC) is the most common
form of well differentiated thyroid cancer and is usually
associated with good prognosis [1]. Recurrence rates are
reported between 10-33% depending on stage and histo-
logical subtype [2]. Common sites for distant metastases
of PTC include mediastinal lymph nodes, lung and bone
[3]. Here, we discuss a patient with recurrent PTC with
distant metastases to mediastinal lymph nodes, lung,
spine, as well as colon. Gastrointestinal metastases of thy-
roid cancer account for 0.5-1% metastatic sites [3]. To
date, there are only a small number of patient reports
documenting metastatic disease from the thyroid to the
colon [4-6].
Radiation treatment of tumors of the colon is not
typically performed as it presents a challenge to visualize
and consistently target mobile abdominal organs. Treat-
ment planning without adequate visualization of the
target area can result in wide treatment margins and ex-
cessive toxicity. Movement of the intra-abdominal organs
can result in underdosing of the target or overdosing of
the surrounding organs. Furthermore, conventional CBCT* Correspondence: justin.lee@sunnybrook.ca
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unless otherwise stated.techniques rely on bony matching, which does not neces-
sarily correlate with internal organ motion. Use of fiducial
markers, such as surgical clips, can narrow the treatment
volume and improve radiation targeting. Previous studies
demonstrate that use of surgical clips for targeting pros-
tate cancer, results in a reduction in total setup error,
smaller planning target volume (PTV) margin and rectal
sparing [7]. Despite these potential benefits, fiducial
markers may also have a negative impact on clinical out-
comes if the PTV margin is significantly reduced without
careful consideration of intrafraction organ motion. [8].
Here, we present a unique case of multi-site metastasis
of papillary thyroid carcinoma including an ulcerated,
bleeding colonic mass. Furthermore, we describe our
experience with image-guided radiation therapy (IGRT)
for palliative treatment to control bleeding of metastatic
disease to the colon.Case presentation
A 67-year old man presented with an ulcerated, bleeding
mass in the colon, shown by biopsy to be metastatic
PTC in May 2014.
He initially presented with a locally advanced thyroid
tumour in 2005 treated with total thyroidectomy and
bilateral neck dissection. Post-surgical pathology re-
vealed the primary lesion to be classic papillary thyroidhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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variants. There was evidence of capsular invasion, extra-
thyroidal extension involving muscle, adherence to the
trachea and involved neck nodes; tumour stage was
pT4N2M0. The patient underwent adjuvant radioactive
iodine, and external beam radiation to a dose of 60Gy
over 30 fractions to the thyroid bed and neck.
In June 2007, the patient developed locoregional recur-
rence which was treated with left neck dissection and
radioactive iodine of 150 millicuries. In December 2009,
chest imaging revealed pulmonary and mediastinal metas-
tases which were treated with a third course of radioactive
iodine of 157 millicuries. In January 2013, the patient pre-
sented with spinal metastases involving the T9, T11, and
L2 vertebrae encroaching on the spinal canal. This was
treated with radiation dose of 20Gy in 5 fractions to con-
trol neuropathy and bony pain.
In June 2014, the patient presented with abdominal
fullness and lower gastrointestinal bleeding. Abdominal
and pelvic CT with contrast showed metastatic deposits
throughout the abdomen and pelvis, with lymphadenop-
athy involving the gastrohepatic ligament, celiac axis, aor-
tocaval and left external iliac regions. The patient was
found to have a hemoglobin (HgB) level of 65 mg/L and
was transfused a total of 4 units of packed red blood cells.
Colonoscopy was performed; an actively bleeding 6.1 ×
1.0 cm ulcerated lesion was dominant in the left colon.
Biopsy of the colon mass was performed and the immuno-
histochemical profile was positive for TTF-1 and CK7,
negative for CDX2, CK20 and HBME1. Immunohisto-
chemistry and morphology were consistent with metastaticFigure 1 Computed tomography of palliative radiotherapy plan witho
radiation field edges (blue) without fiducial markers present. No GTV was vpapillary thyroid cancer. Further surgical management of
the mass was not deemed appropriate given the patient’s
extent of disease and comorbidities. Additional radioactive
iodine treatment was not recommended after considering
the three previous doses and the low likelihood of targeting
the colonic lesion. Therefore, the patient was planned for
radiotherapy with the intent to stop bleeding from the
colonic mass. A palliative dose of 20 Gy in 5 fractions was
chosen to try to alleviate symptoms while limiting toxicity
to the adjacent, unaffected organs at risk.
Colon tumor localization
The initial colonoscopy described the location of the mass
to be distal to the splenic flexure. However, the mass
could not be resolved on diagnostic CT with contrast or
initial CT simulation. Due to this uncertainty, the initial
radiation treatment CTV and PTV encompassed the en-
tire descending colon (Figure 1). It was felt that this large
irradiated volume might cause excessive acute gastrointes-
tinal side effects. Therefore, to better localize the colonic
metastasis, three metallic surgical clips were inserted dur-
ing repeat colonoscopy: proximal, distal and one within
the ulcerated mass. On re-simulation, the surgical clips
were found to be in the left lower quadrant just proximal
to the sigmoid colon. The GTV was contoured to encom-
pass the three clips and the segment of colon defined by
the ends of the clips. Due to uncertainties regarding the
extent of disease and intrafraction organ motion, a volu-
metric CTV expansion of 1 cm was applied followed by
an additional PTV margin of 1 cm. Localization with
the clips reduced the PTV from 393.8 cm3 to 251.5 cm3ut clips. Representative coronal CT image of the CTV (yellow) and
isible therefore the CTV contour included the entire descending colon.
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(Figure 2).
Clinical treatment technique: image guided radiotherapy
with colon fiducial markers
Simulation and treatment were performed with the pa-
tient in the supine position, without contrast, using a
knee support for comfort. Bladder filling was not speci-
fied for the simulation or treatment.
On treatment, daily CBCT verification was performed
using image fusion from the Pinnacle 9.2 Treatment Plan-
ning System (TPS; Philips Healthcare, Andover, MA) to
ensure the PTV encompassed the three clips and CTV
contour. Bony registration was first confirmed on prelim-
inary CBCT and then, if required, any additional shifts
were applied to ensure that all three clips were encom-
passed by the PTV volume. The three clips were well
visualized by radiation therapy staff and centered within
the PTV volume on each of the five treatment days.
Analysis of inter- and intrafractional organ movement
A review of each daily CBCT image and treatment shifts
was performed to determine tumour motion using the
surgical clips as a surrogate to define the GTV. The clips
were contoured in the initial CT simulation scan and all
subsequent CBCT images.
Clip displacement (i.e. inter- and intrafractional move-
ment of the mass) was assessed using Image Fusion from
the Pinnacle 9.2 TPS. Cone beam CT images from eachFigure 2 Computed tomography of palliative radiotherapy plan with
radiation field edges (blue). Three clips were placed within the tumour and
from 393.8 cm3 to 251.5 cm3. The V15 for small bowel loops was reducedtreatment day were fused with the initial planning CT
for bony registration. Displacement was calculated by com-
paring the coordinates of the geometric centers of the con-
toured clip volume (i.e. the GTV) of the initial planning
CT versus daily CBCTs. The average interfraction move-
ment of the clips was 0.69 cm (ranging 0.51-0.98 cm) from
initial planning (Table 1).
On days 4 and 5 of treatment, the patient required add-
itional repositioning/shifting to center the PTV onto the
target. Intrafractional movement (i.e. the difference be-
tween daily pre- and post-shift movement) of the patient
produced a 0.24 cm and 0.41 cm displacement of the tar-
get on days 4 and 5, respectively (Table 2). The clips had
the greatest mean magnitude of displacement in the left-
right dimension (0.83 cm), followed by superior-inferior
(0.51 cm) and antero-posterior (0.44 cm) dimensions (data
not shown). As inter- and intra-fractional displacement is
not yet well understood for tumours located within the
colon, PTV margins were maintained at 1 cm throughout
the treatment course to ensure adequate coverage.
Clinical follow-up
The patient tolerated the palliative course of radiation
treatment well with no gastrointestinal or genitourinary
toxicity observed. Lower gastrointestinal bleeding stopped
within 4 days of completing radiation therapy and post-
treatment HgB level was 95 mg/L; no additional transfu-
sions were required. At six-week follow-up, the patient
did not have any recurrent lower GI bleeding and HgBclips placed. Representative coronal CT image of the CTV (yellow) and
at the distal and proximal extent. The PTV volume was decreased
from 328.0 cm3 to 176.0 cm3.
Table 1 Interfractional displacement of surgical clips on
treatment day from planning







CBCT images were taken at planning and before each day of treatment.
Images were fused with the planning CT image after bony registration.
Displacement of the clips between the each day and planning were
calculated. Pre- and post-shift displacements are measured from the central
coordinates of the GTV.
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admitted to hospital with thromboembolic stroke and died
from complications.
Discussion
Given the complicated and unfortunate course of disease
for this patient, palliative management was recommended
to control lower GI bleeding, avoid further transfusions,
and improve quality of life. Rare abdominal and pelvic me-
tastasis of papillary thyroid cancer presented a challenge
for management, and only a handful of reports have been
published [4-6]. One report documented a 19-year old girl
with a rare cribriform-morular variant of PTC, associated
with familial adenomatous polyposis syndrome [4]. An-
other report described Hurthle cell thyroid carcinoma
metastatic to the sigmoid colon with radioactive iodine re-
sistance [6]. However, these studies were primarily treated
with surgery and did not utilize external beam radiation
therapy for the abdominal and pelvic metastases. As
noted, surgery for this patient was contraindicated due to
the extent of metastatic disease and comorbidities.
Abdominal organ and tumor movements are influenced
by respiration and bladder filling status, leading to irregu-
lar changes in conformity [9]. Abbas et al. reviewed mul-
tiple motion management strategies to control abdominal
organ movement for radiation therapy, including motion
control/suppression methods and respiratory gating dur-
ing treatment; however, movement of the intestines may
present additional challenges due to the relatively unfixedTable 2 Intrafractional movement of the GTV on












4 0.61 0.44 0.21
5 0.64 0.35 0.41
The patient was repositioned on days 4 and 5 after initial CBCT to improve
GTV alignment and conform to PTV margins. The change in magnitude of
intrafractional displacement is shown.nature of the organs compared to other abdominal
organs [9].
Irradiation of the abdomen and pelvis may cause acute
toxicities including nausea, vomiting and diarrhea. For
palliative dose regimens such as 20 Gy in 5 fractions the
reported rates of nausea and/or vomiting range between
30-50% [10-12]. Biological models and clinical studies
suggest that the volume of small bowel loops receiving
15 Gy or more (V15) may be an important factor. A
threshold of V15 > 120 cm3 is associated with >10% risk
of grade 3 or higher acute toxicity [13-15]. We retrospect-
ively contoured the loops of small bowel and evaluated
the V15 for the radiotherapy plans with and without fidu-
cial markers. The preliminary radiation plan resulted in a
V15 of 328 cm3 which would have exposed the patient to
a high risk of severe acute small bowel toxicity[13]. The
plan based on surgical clips for target delineation yielded
close to 50% reduction in the small bowel dose, with a
V15 of 176 cm3, suggesting a potential decrease in the risk
of severe toxicity.
Inter- and intrafractional tumor movement have been
assessed with regards to lung, pancreatic, prostatic, vagi-
nal and hepatic cancers, but not lesions in the colon
[16-20]. Recent case studies have also employed the use
of surgical clips as fiducial markers in radiosensitive
intra-abdominal lymphomas in the duodenum and colon
but did not report on tumour movement and adequacy
of PTV margins [7,9]. Other studies have assessed the
use of fiducial markers and daily CBCT registration in
bladder, pancreas and prostate, which have found signifi-
cant discrepancies between interfractional fiducial marker
location and bony anatomy [21-23]. Despite the improved
tumor visualization with fiducial markers, proper organ
motion data must be assessed to accurately delineate the
target margins to avoid inappropriate dosing [8]. In this
case, CBCT was used to first ensure bony matching and
then to confirm tumour coverage. The clip displacements
after bony registration ranged between 0.21-0.98 cm,
therefore additional shifts were not required and the
clinical impact was limited. In future studies, clip displace-
ment might be used to evaluate systematic errors and
reduce PTV margins.
Conclusion
Here we present a rare case of papillary thyroid cancer
metastasis to the colon treated with a palliative dose of
IGRT to control lower GI bleeding. Surgical clips were
used as fiducial markers with a volumetric expansion of
1 cm for the CTV and 1 cm for the PTV. The main benefit
of the fiducial markers in this case was accurate delineation
of the GTV which allowed for smaller target volumes.
Using daily CBCT, the interfraction and intrafraction clip
movements were measured to be less than 1 cm which was
within the PTV margin chosen for this case.
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IGRT for a colon tumor using surgical clips as fiducial
markers to enhance target localization and verify daily
treatment position. The radiopaque surgical clips provide
a reliable marker for visual verification of a mobile and
otherwise imperceptible lesion.
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